Quantitative Determination Patents (Class 435/39)
-
Publication number: 20120157381Abstract: The invention features compositions comprising agents having cardiac protective activity isolated from epicardial progenitor cells and derivatives thereof, and methods for the use of such compositions.Type: ApplicationFiled: August 29, 2011Publication date: June 21, 2012Applicant: The University of Vermont and State Agriculture CollegeInventor: Jeffrey Spees
-
Publication number: 20120149058Abstract: An apparatus (2) for the automatic testing of substances for carcinogenicity comprises: a plate support (3) on which at least one micro-well plate (1) can be placed; a movable pipetting unit (4) comprising a predetermined number of pipettes (40); a number of containers (5) containing a liquid culture medium (50), the number of containers (5) corresponding to the number of pipettes (40) of the pipetting unit (4); a dish support (6) on which a corresponding number of dishes (60) can be placed, each having a bottom and an upstanding side wall (601); spinning means (63) for spinning the dishes (60); closing means (62) for placing a lid (600) on each of the dishes; transport means (64,65) for transporting the closed dishes (60) to an intermediate storage (8).Type: ApplicationFiled: March 19, 2010Publication date: June 14, 2012Inventor: Dieter Voegelin
-
Publication number: 20120141434Abstract: A method and criteria are provided for selecting expanded hematopoietic stem cell populations for allogenic transplantation, the selected cell populations having high probability of engraftment and positive clinical outcome.Type: ApplicationFiled: May 5, 2010Publication date: June 7, 2012Applicant: Gamida Cell Ltd.Inventors: Tony Peled, Dorit Harati
-
Publication number: 20120142002Abstract: Disclosed is a spontaneously immortalized multipotent mesenchymal cell-line, wherein the cell-line has been isolated from mouse subcutaneous adipose tissue, and wherein the cell-line presents fibroblastoid morphology and expresses Sca-1, c-Kit/CD117, nestin, nucleostemin, CD44 and CD106 markers.Type: ApplicationFiled: December 1, 2011Publication date: June 7, 2012Applicant: UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE "AMEDEO AVOGADRO"Inventors: Maria G. PRAT, Stefano Pietronave, Andrea Zamperone
-
Publication number: 20120142031Abstract: The present invention includes devices, systems, and methods for assaying cells using cell-substrate impedance monitoring. In one aspect, the invention provides cell-substrate impedance monitoring devices that comprise electrode arrays on a nonconducting substrate, in which each of the arrays has an approximately uniform electrode resistance across the entire array. In another aspect, the invention provides cellular assays that use impedance monitoring to detect changes in cell behavior or state. In some preferred aspects, the assays are designed to investigate the affects of compounds on cells, such as cytotoxicity assays.Type: ApplicationFiled: September 23, 2011Publication date: June 7, 2012Inventors: Xiao Xu, Yama Abassi, Xiaobo Wang, Jiangbo Gan
-
Publication number: 20120135983Abstract: The present invention relates to the recognition that inhibition of the base excision repair pathway is selectively lethal in cells which are deficient in HR dependent DNA DSB repair. Methods and means relating to the treatment of cancers which are deficient in HR dependent DNA DSB repair using inhibitors which target base excision repair components, such as PARP, is provided herein.Type: ApplicationFiled: November 1, 2011Publication date: May 31, 2012Inventors: Alan Ashworth, Stephen Jackson, Niall Martin, Graeme Smith
-
Publication number: 20120129212Abstract: The invention relates to methods of monitoring erythropoiesis. In particular, the invention relates to methods of detecting nascent erythrocyte production in vivo as methods for identifying modulators of erythropoiesis.Type: ApplicationFiled: May 25, 2010Publication date: May 24, 2012Applicant: VERTEX PHARMACEUTICALS INCORPORATEDInventor: Mark Wood
-
Publication number: 20120129835Abstract: Methods of preparing and using neural cells derived from human induced pluripotent stem cell (hiPSCs), particularly hiPSCs derived from subjects with schizophrenia are provided. The hiPSC-derived neural cells can be used to screen test compounds and to identify schizophrenia marker functions. The hiPSC-derived neural cells can be used to diagnose and/or assess the severity of schizophrenia in a subject. Further, may the hiPSC-derived neural cells from a subject be used as an in vitro system to identify the most effective candidate among existing drugs for that specific subject (i.e. personalized medicine).Type: ApplicationFiled: November 16, 2011Publication date: May 24, 2012Applicant: SALK INSTITUTE FOR BIOLOGICAL STUDIESInventors: Kristen Brennand, Fred H. Gage
-
Publication number: 20120129211Abstract: Methods and composition for differentiation of pluripotent stem cells are provided. For example, in certain aspects methods including screening of optimal differentiation conditions for a selected stem cell clone in a selected batch of culture medium and use of the determined optimal condition for differentiation into a specific cell lineage.Type: ApplicationFiled: October 19, 2011Publication date: May 24, 2012Inventors: STEVEN KATTMAN, Wen Bo Wang, Peter Fuhrken, Nathan Meyer, Matthew George, Casey Stankewicz
-
Publication number: 20120121608Abstract: Sam68 plays a role in TNF-dependent signaling, including NF-kB signaling and extrinsic activation of apoptosis. In some embodiments, inhibitors of Sam68 are administered to inhibit TNF-dependent signaling, for example to inhibit NF-kB signaling or apoptosis in a patient in need. In some embodiments, functional Sam68 is administered to increase TNF-dependent signaling, for example to induce apoptosis in a patient in need. In some embodiments, methods are provided determining whether the TNF-dependent or TNF-independent branch of a signaling pathway is active in a cell or cells, or for drug screening applications.Type: ApplicationFiled: October 28, 2011Publication date: May 17, 2012Inventors: Parameswaran Ramakrishnan, David Baltimore
-
Publication number: 20120122110Abstract: The present invention relates to a method and kit for the isolation of cells from a sample. The sample is treated with an extraction solution that comprises at least MgCl2 and/or an ionic liquid resulting in the isolation of preferably viable cells.Type: ApplicationFiled: May 31, 2010Publication date: May 17, 2012Applicant: MERCK PATENT GESELLSCHAFT MIT BESDCHRANKTER HAFTUNGInventors: Peter Rossmanith, Patrick Julian Mester, Martin Wagner
-
Patent number: 8173359Abstract: A sample of unknown bacterial spores is added to a test strip. The sample of unknown bacterial spores is drawn to a first sample region on the test strip by capillary action. Species-specific antibodies are bound to the sample when the unknown bacterial spores match the species-specific antibodies, otherwise the sample is left unbound. DPA is released from the bacterial spores in the bound sample. The terbium ions are combined with the DPA to form a Tb-DPA complex. The combined terbium ions and DPA are excited to generate a luminescence characteristic of the combined terbium ions and DPA to detect the bacterial spores. A live/dead assay is performed by a release of the DPA for live spores and a release of DPA for all spores. The detection concentrations are compared to determine the fraction of live spores.Type: GrantFiled: June 4, 2007Date of Patent: May 8, 2012Assignee: California Institute of TechnologyInventors: Adrian Ponce, Gregory H. Bearman
-
Publication number: 20120100521Abstract: Microdevices are disclosed to efficiently, accurately, and rapidly isolate and enumerate rare cells, such as circulating tumor cells, from liquids such as whole blood. The system employs multiple parallel meandering channels having a width on the order of 1-2 cell diameters. The microdevices can be produced at low-cost, may readily be automated, and in many instances may be used without pre-processing of the sample. They may be used to isolate and enumerate rare cells, including for example the detection and diagnosis of cancers, cancer staging, or evaluating the effectiveness of a therapeutic intervention, or detecting pathogenic bacteria. The device may optionally be used to nondestructively capture and later to release target cells.Type: ApplicationFiled: May 13, 2009Publication date: April 26, 2012Inventors: Steven A. Soper, Michael C. Murphy, June Feng, Robin L. McCarley, André A. Adams
-
Publication number: 20120094327Abstract: The disclosure provides culture devices and methods useful for detecting acid-producing bacteria in a sample. The devices include a nutrient medium and a pH indicator to detect and differentiate acid-producing microorganisms, such as lactic acid bacteria. Methods of use include detecting or enumerating acid-producing microorganisms. The methods further provide for the detection of gas-producing acid-producing bacteria.Type: ApplicationFiled: June 15, 2010Publication date: April 19, 2012Inventors: Robert F. Young, Patrick A. Mach, Michael E. Hughes, Christine A. Binsfeld, Jason W. Bjork, Mara S. Reif-Wenner, Henry J. Lubrant
-
Publication number: 20120094281Abstract: Articles are provided for the detection of cells in a sample. The articles include a release element comprising a cell extractant. The release element includes a shell structure that controls the release of the cell extractant into a liquid mixture containing the sample. Methods of use are also disclosed.Type: ApplicationFiled: May 6, 2010Publication date: April 19, 2012Inventors: Raj Rajagopal, Smarajit Mitra, Matthew D. Reier
-
Publication number: 20120082977Abstract: Articles are provided for the detection of cells in a sample. The articles include a release element. The release element comprises an encapsulating agent and a cell extractant. The release element controls the release of the cell extractant into a liquid mixture containing the sample. Methods of use are also disclosed.Type: ApplicationFiled: May 6, 2010Publication date: April 5, 2012Inventors: Raj Rajagopal, Robin E. Wright, Caroline M. Ylitalo, Smarajit Mitra, Matthew D. Reier
-
Publication number: 20120076797Abstract: Methods and compositions are provided for modulating Kit/stem cell factor receptor (SCFR)/CD117 and interleukin 4 receptor (IL-4R) signaling in a cell in vitro and in vivo, and for identifying candidate agents with activity in modulating Kit and IL-4R signaling. These methods find particular use in treating disorders of the hematopoietic system and in modulating hematopoietic stem cell expansion.Type: ApplicationFiled: July 12, 2011Publication date: March 29, 2012Inventors: Atul J. Butte, Kenneth Weinberg, Shivkumar Venkatasubrahmanyam, Maheswaran Mani
-
Publication number: 20120064567Abstract: An active sieve device for the isolation and characterization of bio-analytes is provided, comprising a substrate for supporting the bio-analytes. The substrate comprises a plurality of interconnections and a plurality of regions, each region comprising a hole and at least one electrode embedded in or located on the substrate and electrically associated with the hole. Each region further comprises at least one transistor integrated in the substrate and operably connected to the at least one electrode and to at least one of the plurality of interconnections.Type: ApplicationFiled: September 8, 2011Publication date: March 15, 2012Applicant: IMECInventors: Tim Stakenborg, Chengxun Liu, Liesbet Lagae, Ronald Kox
-
Publication number: 20120058087Abstract: The present invention relates to methods for diagnosing and treatment of a dormant infection of at least one pathogen. The invention further relates to a composition comprising an anti-dormancy factor as well as to said composition for use in a method of diagnosis or treatment and also to a method for manufacturing said composition. The invention further relates to a kit of parts comprising, inter alia, said composition. The invention also relates to a method for activating a dormant infection.Type: ApplicationFiled: December 18, 2009Publication date: March 8, 2012Applicant: Kobenhavns UniversitetInventors: Morten Rønn Petersen, Anders Miki Bojesen
-
Publication number: 20120052485Abstract: The present invention provides a naturally based Sperm Separation System (SSS) for separation of at least a portion of sperm cell populations (SCP) within an original semen sample, such that an en?ched SCP sample is obtained, comprising a a sperm separation device, comprising ?) a first chamber adapted to contain at least a portion of said original semen sample, said first chamber is characterized by predetermined 3D shape and volume, V, said first chamber is bounded by a rim such that said original sample is kept below said rim, n) a second chamber in physical communication with said first chamber and said nm, said second chamber is characterized by predetermined 3D shape and volume, V1, said second chamber is adapted to reside said enriched SCP sample, b incubation means, adapted to socket at least one of said cell separation device and to homogeneously thermoregulate the temperature within the sameType: ApplicationFiled: April 22, 2010Publication date: March 1, 2012Applicant: LOTUS BIO (NYMPHAEA) LTD.Inventors: Vered Shany, Isaac Tavori
-
Publication number: 20120045465Abstract: The present invention relates to a WT1 peptide which has an amino acid sequence consisting of contiguous amino acids derived from a WT1 protein and induces WT1-specific helper T cells by binding to an MHC class II molecule, a pharmaceutical composition comprising them and the like.Type: ApplicationFiled: April 22, 2010Publication date: February 23, 2012Inventor: Haruo Sugiyama
-
Publication number: 20120039851Abstract: The present invention relates to the field of therapy and prophylaxis of vascular tissue damage and/or complications and/or disease of vascular tissue by vascular regeneration and endothelium repair. The inventors have found that administration of an androgen receptor agonist alleviates one or more adverse vascular diseases and/or vascular complications thereof or adverse effects of androgen deficiency, with implications for prophylactic and therapeutic interventions.Type: ApplicationFiled: July 4, 2008Publication date: February 16, 2012Inventors: Daniel Peter Sieveking, Martin Kean Chong Ng
-
Publication number: 20120035347Abstract: The present invention provides biomarkers of sensitivity to interferon alfa (IFN-?). These IFN-? sensitivity biomarkers are useful, inter alia, to identify patients who are most likely to benefit from treatment with pharmaceutical compositions of IFN-?, in methods of treating patients having a disease susceptible to treatment with interferon alfa, and in methods for selecting the most appropriate therapy for such patients.Type: ApplicationFiled: April 13, 2010Publication date: February 9, 2012Applicant: Schering CorporationInventor: Antoine Jean Yver
-
Publication number: 20120028275Abstract: The invention relates to a membrane which can be used for cultivating adherent or suspension cells, in particular adherent cells, wherein said membrane allows for the adhesion and proliferation of the cells due to modification of the membrane surface with a combination of at least one extracellular matrix protein, at least one extracellular matrix (proteo-) glycan, and at least one heparin-binding growth factor. The invention further relates to a method for preparing said modified or coated membrane which can be used for the cultivation of cells, in particular adherent cells, and to methods of using such membrane for the cultivation of cells, in particular adherent cells.Type: ApplicationFiled: July 20, 2011Publication date: February 2, 2012Applicant: GAMBRO LUNDIA ABInventors: Verena Kieferle, Markus Neubauer
-
Publication number: 20120028251Abstract: The disclosure provides articles and methods useful for detecting a discrete source of DNase activity. DNase-producing microorganisms can be detected. The device can further include selective agents and/or indicators to differentiate groups or species microorganisms. Methods of use include detecting or enumerating DNase-producing microorganisms.Type: ApplicationFiled: February 22, 2010Publication date: February 2, 2012Inventors: Patrick A. Mach, Michelle L. Rosauer, Michael E. Hughes
-
Publication number: 20120028297Abstract: The present invention refers to articles for collecting samples from a surface, articles for microbiological analyses of said samples, and methods of use of said articles. The articles include sample collectors, sample housings with optional barrier layers, and sample-ready reagent strips comprising hydrophilic agents to grow and detect microorganisms. The disclosure includes methods to collect, detect, and quantify microorganisms in a surface sample.Type: ApplicationFiled: November 20, 2008Publication date: February 2, 2012Applicant: 3M Innovative Properties CompanyInventors: Cynthia D. Zook, Robert H. Silbernagel, Barbara L. Horter, Henry J. Lubrant, Robert E. Koeritzer
-
Publication number: 20120021402Abstract: A biosensor has one or more field effect transistors each comprising a source region and a drain region separated by a channel region and a gate positioned offset and spaced from the channel region. The biosensor also has one or more molecular probes coupled to at least one of the channel region and the offset gate, the one or more molecular probes configured to mate with at least one target. A method for detection of a target is also disclosed. One or more targets are immobilized as an electric field shunt between an offset gate and a channel region for one or more biosensors. A target measurement value is determined in proportion to a number of the one or more biosensors having the electric field shunt.Type: ApplicationFiled: July 20, 2010Publication date: January 26, 2012Inventor: Michael POTTER
-
Publication number: 20120014931Abstract: Motor neuron progenitor (MNP) cells and populations of MNP cells, are provided, in particular, populations of human late stage MNP cells having a purity of greater than about 65% late stage MNP cells and high-purity populations of MNP cells having greater than 95% viable cells, as well as method of making and using the same, including deriving late stage MNP cells from pluripotent embryonic stem cells, producing high-purity populations of late stage MNP cells, producing populations of viable MNP cells, transporting viable MNP cells, and transplanting MNP cells.Type: ApplicationFiled: September 23, 2011Publication date: January 19, 2012Applicant: California Stem Cell, Inc.Inventor: Aleksandra J. Poole
-
Publication number: 20120015398Abstract: The present invention relates to a method for the semi-quantitative determination of cariogenic bacteria in a sample of saliva and/or plaque, in which the microorganisms contained in a sample of plaque or saliva are brought into contact with a carbon source that is fermented to acid by the cariogenic bacteria. The microorganisms are then incubated under conditions which make possible selective acid formation by the cariogenic bacteria. The acid formation is then detected by determining the pH at least once within a period of 12 hours after adding the carbon source, wherein the cariogenic bacteria are determined semi-quantitatively in the sample by comparison of the pH with at least one reference value. In addition, the invention provides kits for carrying out such methods.Type: ApplicationFiled: July 12, 2011Publication date: January 19, 2012Applicant: IVOCLAR VIVADENT AGInventors: Manuela Bischof, Carlo Bolis, Urs Lendenmann, Volker Rheinberger
-
Publication number: 20120010597Abstract: A method of inducing dendritic cell (DC) development by administering Macrophage-Colony Stimulating Factor is provided. M-CSF induces DCs to differentiate into subtypes, for example plasmacytoid DCs and conventional DCs. Induction with M-CSF can be achieved in vitro from hematopoietic precursors, such as bone marrow cells, or in vivo. In vitro, M-CSF-derived DCs can be used to produce cytokines and to stimulate other immune response cells. M-CSF can also be used to induce precursor cells removed from an animal to develop into DCs. In addition, these isolated DCs can be exposed to antigens to stimulate a specific immune response when reintroduced into the animal. Treatments for cancers, such as Acute Myeloid Leukemia, and autoimmune diseases such as Systemic Lupus Erythematosus, are also provided in the invention.Type: ApplicationFiled: September 21, 2011Publication date: January 12, 2012Applicant: BAVARIAN NORDIC A/SInventors: Hubertus HOCHREIN, Meredith O'KEEFFE
-
Publication number: 20120003687Abstract: The invention features methods of quantifying cells in a sample by lysing the cells followed by the measurement of at least one intracellular component. Methods of the invention are especially useful for quantifying small numbers of cells, e.g., over a large surface area or volume compared to the cell size. In a preferred embodiment, methods of the invention are performed using a microfluidic device.Type: ApplicationFiled: April 21, 2008Publication date: January 5, 2012Inventors: Mehmet Toner, Rashid Bashir, Xuanhong Cheng, Utkan Demirci, Daniel Irimia, William R. Rodriguez, Liju Yang, Lee Zamir, Yi-Shao Liu
-
Publication number: 20120003661Abstract: Methods and devices are provided for the rapid and specific detection of target microorganisms, cells, and the like. In one embodiment, the methods involve contacting a target microorganism (e.g., in a sample) with a permeabilization reagent that selectively permeabilizes or lyses the microorganism; contacting the selectively permeabilized microorganism with a detection reagent that is taken into the selectively permeabilized organism or that contacts metabolites or enzymes released by the selectively permeabilized microorganism, where the detection reagent produces a signal in the presence of said metabolites or enzymes; and detecting a signal produced by the detection reagent in the presence of the metabolites or enzymes wherein the strength of the signal indicates the presence and/or amount of the target microorganism in the sample.Type: ApplicationFiled: June 27, 2011Publication date: January 5, 2012Applicant: C3 JIAN, INC.Inventors: Randal H. Eckert, Chris Kaplan, Jian He, Daniel K. Yarbrough, Maxwell Anderson, Jee-Hyun Sim
-
Publication number: 20110318777Abstract: The invention relates to a device for metering cells and also to a method for metering cells. Furthermore, the invention relates to the use of the device for metering cells.Type: ApplicationFiled: June 9, 2011Publication date: December 29, 2011Applicant: KIST-EUROPE FORSCHUNGSGESELLSCHAFT MBHInventors: Jungtae Kim, Holger Krause, Jihwang Park, Sebastian Beck
-
Publication number: 20110312022Abstract: Methods of introducing sentinel traits into foundation seed are described. The frequency of occurrence of the sentinel trait in the hybrid seed product relative to the frequency of the sentinel trait in a pollinator seed product are used to determine the percentage of hybridity in modified hybrid varieties.Type: ApplicationFiled: September 10, 2010Publication date: December 22, 2011Applicant: AGRIGENETICS, INC.Inventor: Danielson B. Gardner
-
Publication number: 20110300551Abstract: The present invention provides an automated method for capturing and detecting circulating melanoma cells (CMC's) in the blood of patients with melanoma. The absolute number of circulating melanoma cells detected in the peripheral blood tumor load is, in part, a factor in prediction of survival, time to progression, and response to therapy.Type: ApplicationFiled: June 8, 2011Publication date: December 8, 2011Inventors: Galla Chandra Rao, Mark C. Connelly
-
Publication number: 20110289608Abstract: Provided are antisense oligonucleotides and other agents that target and modulate IL-17 and/or IL-23 signaling activity in a cell, compositions that comprise the same, and methods of use thereof. Also provided are animal models for identifying agents that modulate 17 and/or IL-23 signaling activity.Type: ApplicationFiled: May 13, 2011Publication date: November 24, 2011Applicant: AVI BIOPHARMA, INC.Inventors: Frederick J. Schnell, Patrick L. Iversen, Dan V. Mourich
-
Publication number: 20110275089Abstract: Cellular and genetic signatures and methods of using same for subcategorizing stage III melanoma tumors are described herein. The signatures and methods are particularly useful with regard to establishing more distinct criteria on which basis to differentiate stage IIIB and IIIC melanoma patients. Assessment of the cellular and genetic signatures of a melanoma sample using methods described herein yields information on which basis differential survival duration and sensitivity to various cancer therapies can be predicted for a Stage IIIB or Stage IIIC melanoma patients. As described herein, gene expression profiling, determination of mitotic index (MI), and quantification of tumor infiltrating leukocytes (TILs) and CD3+ cells in metastatic lesions may be utilized to predict or assess drug response, drug sensitivity, and clinical outcome in metastatic melanoma patients.Type: ApplicationFiled: February 17, 2011Publication date: November 10, 2011Inventors: Dusan Bogunovic, Nina Bhardwaj, David O'Neill
-
Publication number: 20110275115Abstract: Stains that are specific for calcium ion are used to assess and predict the effects of various treatments on the viability of cell types contained in a sample, wherein said stain detects endothelial cells that have massive calcium accumulation death.Type: ApplicationFiled: April 13, 2011Publication date: November 10, 2011Inventor: Larry M. WEISENTHAL
-
Publication number: 20110262961Abstract: The present invention relates to compositions and methods for the reduction of atherosclerotic plaques and the decrease in the level of total serum cholesterol, triglycerides, serum LDL cholesterol, and serum HDL cholesterol. The present invention also relates to methods for the diagnosis, prevention and treatment of atherosclerosis and mycoplasma associated diseases.Type: ApplicationFiled: March 28, 2011Publication date: October 27, 2011Inventor: MARIA DE LOURDES HIGUCHI
-
Publication number: 20110262467Abstract: The invention relates to novel artificial antigen presenting cells (aAPCs). The aAPC comprises at least one stimulatory ligand and at least one co-stimulatory ligand where the ligands each specifically bind with a cognate molecule on a T cell of interest, thereby mediating expansion of the T cell. The aAPC of the invention can further comprise additional molecules useful for expanding a T cell of interest. The aAPC of the invention can be used as an “off the shelf” APC that can be readily designed to expand a T cell of interest. Also, the aAPC of the invention can be used identify the stimulatory, co-stimulatory, and any other factors that mediate growth and expansion of a T cell of interest. Thus, the present invention provides powerful tools for development of novel therapeutics where activation and expansion of a T cell can provide a benefit.Type: ApplicationFiled: June 8, 2010Publication date: October 27, 2011Inventors: James L. Riley, Carl H. June, Robert H. Vonderheide, Nicole Aqui, Megan M. Suhoski
-
Publication number: 20110256531Abstract: Articles (610) are provided for the detection of cells in a sample. The articles include a hydrogel (640) comprising a cell extractant. Methods of use are also disclosed.Type: ApplicationFiled: September 28, 2009Publication date: October 20, 2011Applicant: 3M INNOVATIVE PROPERTIES COMPANYInventors: Raj Rajagopal, Matthew D. Reier, Robin E. Wright, Caroline M. Ylitalo
-
Publication number: 20110250633Abstract: Device for automatically analyzing micro organisms in an aqueous sample using filter cytometry comprising at least one filter holder and processing modules, wherein the filter holder is arranged to contain a filter for receiving the sample, wherein the processing modules comprise sample application means for applying the sample to the filter in the holder and imaging means for imaging the micro organisms on the filter, wherein the device furthermore comprises displacement means for automatically moving the filter holder between the processing modules and wherein each of the modules and the filter holder are arranged to removable connect for interaction.Type: ApplicationFiled: October 7, 2008Publication date: October 13, 2011Inventor: Gijsbert Johan Jansen
-
Publication number: 20110250589Abstract: The present invention pertains to the monitoring and treatment of lung transplant recipients. In particular, the invention pertains to the use of biomarkers to predict or detect post-lung transplantation complications (e.g., organ rejection, acute organ rejection, organ injury, bronchiolitis obliterans, bronchiolitis obliterans syndrome, organizing pneumonia), fibroproliferative repair responses, interstitial lung diseases (e.g., idiopathic pulmonary fibrosis and other fibrotic lung diseases), and other immune-mediated lung diseases (e.g., graft versus host disease, scleroderma).Type: ApplicationFiled: January 21, 2011Publication date: October 13, 2011Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventor: Vibha Lama
-
Publication number: 20110244511Abstract: A thin film culture plate device useful for detecting hemolysin-producing microorganisms is included. The device can further include selective agents and/or indicators to differentiate groups or species microorganisms. Methods of use include detecting or enumerating hemolysin-producing microorganisms.Type: ApplicationFiled: December 8, 2009Publication date: October 6, 2011Applicant: 3M INNOVATIVE PROPERTIES COMPANYInventors: Patrick A. Mach, Michelle L. Rosauer
-
Publication number: 20110236411Abstract: The present invention relates to MHC-peptide complexes and uses thereof in the diagnosis of, treatment of or vaccination against a disease in an individual. More specifically the invention discloses MHC complexes comprising Mycobacterium tuberculosis antigenic peptides and uses there of.Type: ApplicationFiled: September 29, 2008Publication date: September 29, 2011Applicant: DAKO DENMARK A/SInventors: Jørgen Scholler, Liselotte Brix, Henrik Pedersen, Tina Jakobsen
-
Publication number: 20110236919Abstract: A process to temporarily and selectively control the dissolved concentration of CO in the feed medium portion of a fermentation liquid by addition of a surface tension active compound (STAC), particularly during seed train scale-up operations and during recovery from process upsets, to support improved production of biofuels from a syngas fermentation. The process inoculates the fermentation liquid when the cell density level is from 0.05 to 0.5 OD with the surface tension active compound at a concentration of from 20 to 800 mg per liter of syngas fermentation liquid. The surface tension active compound may be a polyol or glycol.Type: ApplicationFiled: March 24, 2010Publication date: September 29, 2011Inventors: James Allen Zahn, Seth William Fischbein
-
Publication number: 20110183371Abstract: A disposable microbe-collecting carrier cartridge and a carrier treating apparatus which efficiently convert microbes collected on a carrier into a solution and prevent variations in the amount of retrieval of microbes upon concentration on a filter are provided. A cartridge formed of an upper lid having a plurality of through holes, a container in an inverted-cone shape having both of a liquid storage sink unit having a filter at the bottom and an air suction path, and a support base for setting up a thermoplastic carrier, such as gelatin, and a carrier treating apparatus formed of a dispensing nozzle for liquid supply, a liquid supply mechanism, a liquid heating mechanism, and a suction pump for filtration are prepared. Warm water is supplied onto the filter set up on a bottom surface of the inverted-cone-shaped container and is stored in the liquid storage sink, thereby causing the carrier to make contact with the warm water.Type: ApplicationFiled: June 25, 2009Publication date: July 28, 2011Inventors: Hideyuki Noda, Masahiro Okanojo, Kenko Uchida, Norihito Kuno
-
Publication number: 20110177549Abstract: The present invention provides a method, kit and system for determining a quantitative value indicative of the number of culturable microbial cells, such as E. Coli, Ps. Aeruginosa or a mixture of microbial cells (e.g.Type: ApplicationFiled: July 9, 2009Publication date: July 21, 2011Inventors: Vladimir Glukhman, Elon Kaplan
-
Publication number: 20110177548Abstract: An apparatus and method for increasing the efficiency of finding a field of focus, and for increasing the accuracy of field of view in reading slides with fluorescent microscopy technology, including tuberculosis slides.Type: ApplicationFiled: January 3, 2011Publication date: July 21, 2011Inventors: Christopher J. Graham, Craig Stout
-
Patent number: RE43467Abstract: The present invention features a novel combination therapy useful in the treatment of autoimmune disease that increases or maintains the number of functional cells of a predetermined type in a mammal by killing or inactivating autoimmune cells and re-educating the host immune system.Type: GrantFiled: October 25, 2010Date of Patent: June 12, 2012Assignee: The General Hospital CorporationInventor: Denise Faustman